Protyon (private company)
See something wrong or missing? Let us know
Offices:Groningen
Business model:B2B
Protyon is a Dutch, Groningen-based health-tech start-up developing predictive software based on computational molecular modeling and artificial intelligence (AI) to support patient-specific decision-making in the treatment of lung cancer.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 656k
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Protyon
Name | Criteria | |
---|---|---|
![]() |
Valink Therapeutics
63%
|
|
![]() |
Nori Health
60%
|
|
![]() |
Relevium
60%
|
|
![]() |
NextImmune
60%
|
|
![]() |
Qairn
60%
|
|
![]() |
Signatur Biosciences
60%
|
|
![]() |
Holifya
60%
|
|
![]() |
AbolerIS Pharma
58%
|
|
![]() |
Atai Life Sciences
58%
|
|
![]() |
Athera
58%
|
|